Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

FDA approves first treatment targeting muscle loss in spinal muscular atrophy

Read Now

News and Insights

Showing items 1 to3 of 6

Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition
Insight
Our Take Newsletter
June 15, 2026

GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition

Learn More
June 15, 2026
IDN trends, challenges, and leadership
Health systems gain AI governance controls as collaborations proliferate
Insight
Our Take Newsletter
June 8, 2026

Health systems gain AI governance controls as collaborations proliferate

Learn More
June 8, 2026
Digital health and emerging technologies
Sutter and Allina Health advance plans to combine
Insight
Our Take Newsletter
June 1, 2026

Sutter and Allina Health advance plans to combine

Learn More
June 1, 2026
IDN trends, challenges, and leadership
UnitedHealth’s Optum Rx PBM to shift to transparent, fee-based model
Insight
Our Take Newsletter
May 18, 2026

UnitedHealth’s Optum Rx PBM to shift to transparent, fee-based model

Learn More
May 18, 2026
Pharmacy, PBMs and drug pricing
UPMC to acquire Trinity Health from CommonSpirit, WakeMed to merge with Advocate’s Atrium Health
Insight
Our Take Newsletter
May 11, 2026

UPMC to acquire Trinity Health from CommonSpirit, WakeMed to merge with Advocate’s Atrium Health

Learn More
May 11, 2026
IDN trends, challenges, and leadership
Regeneron’s ‘groundbreaking’ Otarmeni gains FDA approval
Insight
Our Take Newsletter
May 4, 2026

Regeneron’s ‘groundbreaking’ Otarmeni gains FDA approval

Learn More
May 4, 2026
Pharma strategy, engagement, and market access
OpenAI unveils GPT-Rosalind to support life sciences research
Insight
Our Take Newsletter
April 27, 2026

OpenAI unveils GPT-Rosalind to support life sciences research

Learn More
April 27, 2026
Digital health and emerging technologies
Do AI chatbots pose risks for consumers and providers?
Insight
Our Take Newsletter
April 20, 2026

Do AI chatbots pose risks for consumers and providers?

Learn More
April 20, 2026
Digital health and emerging technologies
Gilead announces third acquisition of 2026
Insight
Our Take Newsletter
April 13, 2026

Gilead announces third acquisition of 2026

Learn More
April 13, 2026
IDN trends, challenges, and leadership
The uptick in Big Pharma M&A activity continues
Insight
Our Take Newsletter
April 6, 2026

The uptick in Big Pharma M&A activity continues

Learn More
April 6, 2026
IDN trends, challenges, and leadership
Nearly one-third of U.S. adults use AI to get health information, surveys show
Insight
Our Take Newsletter
March 30, 2026

Nearly one-third of U.S. adults use AI to get health information, surveys show

Learn More
March 30, 2026
Digital health and emerging technologies
Sutter, Allina Health announce intent to merge
Insight
Our Take Newsletter
March 23, 2026

Sutter, Allina Health announce intent to merge

Learn More
March 23, 2026
IDN trends, challenges, and leadership
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.